6 hours ago
Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it
The NHS spent £574m on tirzepatide (Mounjaro) last year, an almost fivefold annual increase and around 5% of its total prescribing bill of £11.6bn, new data show. The increase—driven by rising prescription numbers and higher drug prices—comes... Read more.
Owner: Apollo Global Management (Vanguard Group, Largest Shareholder) through Yahoo, Inc.
Owner: Yemeni Government
Owner: Yemeni Government
More from British Medical Journal
Owner: British Medical Association
Owner: British Medical Association
Owner: British Medical Association
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
